The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

Wieslawa H. Dragowska(BC Cancer Agency), Marcel B. Bally(BC Cancer Agency)

BMC Cancer

October 1, 2011

10.1186/1471-2407-11-420

Cited by 28

Related Papers

Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer

|PLoS ONE|2013|101

QLT0267, a small molecule inhibitor targeting integrin-linked kinase (ILK), and docetaxel can combine to produce synergistic interactions linked to enhanced cytotoxicity, reductions in P-AKT levels, altered F-actin architecture and improved treatment outcomes in an orthotopic breast cancer model

|Breast Cancer Research|2009|73

Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent

|International Journal of Nanomedicine|2017|65

Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1

|Oncogene|2010|49

Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model

|PLoS ONE|2013|28